Anocca Appoints Martin Welschof to Board of Directors

SÖDERTÄLJE, Sweden, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Anocca AB, a leading TCR-T1 cell therapy company, today announced the appointment of Martin Welschof to its Board of Directors. Martin Welschof is currently CEO of BioInvent International AB, a listed clinical-stage cancer immunotherapy…#sweden #anoccaab #tcr #martinwelschof #boardofdirectors #martin #phd #hansstråberg #anocca #reaganjarvis
Source: Reuters: Health - Category: Consumer Health News Source Type: news